Ads
related to: current research into dementia patients today- Learn About Treatment
Discover the Mechanism Of Action
For An FDA-Approved AD Option.
- HCP Support Resources
Download Patient Support Tools And
Help Eligible Patients Gain Access.
- Learn About Treatment
agingcare.com has been visited by 100K+ users in the past month
wiserlifestyles.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
An experimental nasal spray has helped clear toxic protein buildups in the brains of mouse models of Alzheimer's. Its developers believe the spray may help delay Alzheimer's by at least a decade.
Dementia is a devastating condition that impacts almost 10% of older adults in the U.S. With that, it’s understandable to want to do what you can to lower the risk of developing it in the future ...
One study published in December 2022 found that semaglutide lowered the risk of dementia in patients with type 2 diabetes. Another study found that fellow GLP-1 medication liraglutide may protect ...
Psychological therapies for dementia are starting to gain some momentum. [ when? ] Improved clinical assessment in early stages of Alzheimer's disease and other forms of dementia , increased cognitive stimulation of the elderly, and the prescription of drugs to slow cognitive decline have resulted in increased detection in the early stages.
The Nun Study of Aging and Alzheimer's Disease is a continuing longitudinal study, begun in 1986, to examine the onset of Alzheimer's disease. [1] [2] David Snowdon, an Epidemiologist and the founding Nun Study investigator, started the Nun Study at the University of Minnesota, later transferring the study to the University of Kentucky in 1990. [3]
Further research into molecules like miR-212-3p might shed new light on potential therapeutic approaches for Alzheimer's disease, possibly alongside interventions targeted at APP. [21] [22] This type accounts for no more than 10–15% of EOFAD. [medical citation needed] As of 2023, the count of known pathogenic APP mutations stands at just over ...
Ad
related to: current research into dementia patients today